{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:20:12Z","timestamp":1783689612203,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009845","name":"Ovarian Cancer Research Foundation","doi-asserted-by":"publisher","award":["GA-2023-05"],"award-info":[{"award-number":["GA-2023-05"]}],"id":[{"id":"10.13039\/100009845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["827115"],"award-info":[{"award-number":["827115"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mater Foundation Smiling for Smiddy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunogenic cell death (ICD) is a type of cell death that can enhance anti-tumour immune responses of chemotherapies and targeted therapies by releasing DAMPs and cytokines that activate dendritic cells and T cells, thereby engaging the patient\u2019s immune system to combat the cancer. Pyroptosis and necroptosis are strongly immunogenic because they release DAMPs and inflammatory signals through pore-forming proteins, whereas apoptosis can be tolerogenic. This immunogenic response is contingent on a functional immune system. Unfortunately, most conventional chemotherapies and many targeted therapies also impair the immune system. Here, we investigated the mechanism by which the tumour-selective treatment of Checkpoint kinase 1 inhibitor (CHK1i) combined with low-dose hydroxyurea (LDHU) promotes ICD and anti-tumour immunity. We show that CHK1i+LDHU induces S-phase arrest and caspase-dependent lytic cell death with features of pyroptosis, including gasdermin E cleavage, but cell death was not dependent solely on gasdermin cleavage. Inhibiting caspases was sufficient to block both tumour cell killing and treatment immunogenicity. The mechanism does not rely on any single caspase or gasdermin, consistent with the contributions from multiple caspase-dependent processes. By contrast, doxorubicin that predominantly triggers apoptosis was less effective at stimulating anti-tumour immune responses despite triggering similar levels of cell death. These findings demonstrate that caspase-dependent lytic cell death with pyroptotic features promotes a more effective stimulus for anti-tumour immunity.<\/jats:p>","DOI":"10.1038\/s41418-026-01808-4","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:37:38Z","timestamp":1783687058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["S-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancers"],"prefix":"10.1038","author":[{"given":"Rituparna","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si En","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-7191","authenticated-orcid":false,"given":"Dan A.","family":"Erkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia Maria Xavier","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koyo","family":"Kinase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khai Yee","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7812-7701","authenticated-orcid":false,"given":"Alexis","family":"Bonfim-Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enaam","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Daignault-Mill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1110-1969","authenticated-orcid":false,"given":"Yoon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Jannah","family":"Abdul Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Yee","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Lisa Li-Ann","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-9814","authenticated-orcid":false,"given":"Sharad","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8120-0973","authenticated-orcid":false,"given":"Zhen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3928-5360","authenticated-orcid":false,"given":"Nikolas K.","family":"Haass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2714-8411","authenticated-orcid":false,"given":"Mathew JK","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-3244","authenticated-orcid":false,"given":"Andrew E.","family":"Aplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3933-1651","authenticated-orcid":false,"given":"Brian","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"1808_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1158\/2159-8290.CD-20-0805","volume":"11","author":"SR Rosenbaum","year":"2021","unstructured":"Rosenbaum SR, Wilski NA, Aplin AE. Fueling the fire: inflammatory forms of cell death and implications for cancer immunotherapy. Cancer Discov. 2021;11:266\u201381.","journal-title":"Cancer Discov"},{"key":"1808_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23:487\u2013500.","journal-title":"Nat Immunol"},{"key":"1808_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.it.2013.03.005","volume":"34","author":"S Zelenay","year":"2013","unstructured":"Zelenay S, Reis e Sousa C. Adaptive immunity after cell death. Trends Immunol. 2013;34:329\u201335.","journal-title":"Trends Immunol"},{"key":"1808_CR4","doi-asserted-by":"crossref","unstructured":"Birmpilis AI, Paschalis A, Mourkakis A, Christodoulou P, Kostopoulos IV, Antimissari E, et al. Immunogenic cell death, DAMPs and prothymosin \u03b1 as a putative anticancer immune response biomarker. Cells. 2022;11:1415.","DOI":"10.3390\/cells11091415"},{"key":"1808_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1309635","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang M, Yu F, Zhang Y, Li P. Programmed cell death in tumor immunity: mechanistic insights and clinical implications. Front Immunol. 2023;14:1309635.","journal-title":"Front Immunol"},{"key":"1808_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020;21:678\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1808_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/imr.12541","volume":"277","author":"B Tummers","year":"2017","unstructured":"Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev. 2017;277:76\u201389.","journal-title":"Immunol Rev"},{"key":"1808_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","volume":"30","author":"E Vringer","year":"2023","unstructured":"Vringer E, Tait SWG. Mitochondria and cell death-associated inflammation. Cell Death Differ. 2023;30:304\u201312.","journal-title":"Cell Death Differ"},{"key":"1808_CR9","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.cellsig.2015.01.020","volume":"27","author":"J Vera","year":"2015","unstructured":"Vera J, Raatz Y, Wolkenhauer O, Kottek T, Bhattacharya A, Simon JC, et al. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells. Cell Signal. 2015;27:951\u201360. https:\/\/doi.org\/10.1016\/j.cellsig.2015.01.020.","journal-title":"Cell Signal"},{"key":"1808_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaw2004","volume":"4","author":"AG Snyder","year":"2019","unstructured":"Snyder AG, Hubbard NW, Messmer MN, Kofman SB, Hagan CE, Orozco SL, et al. Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Sci Immunol. 2019;4:eaaw2004.","journal-title":"Sci Immunol"},{"key":"1808_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-025-00837-0","volume":"26","author":"Y Bai","year":"2025","unstructured":"Bai Y, Pan Y, Liu X. Mechanistic insights into gasdermin-mediated pyroptosis. Nat Rev Mol Cell Biol. 2025;26:501\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1808_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ebiom.2017.1009.1016","volume":"24","author":"AE Vilgelm","year":"2017","unstructured":"Vilgelm AE, Cobb P, Malikayil K, Flaherty D, Andrew Johnson C, Raman D, et al. MDM2 antagonists counteract drug-induced DNA damage. EBioMedicine. 2017;24:43\u201355. https:\/\/doi.org\/10.1016\/j.ebiom.2017.1009.1016.","journal-title":"EBioMedicine"},{"key":"1808_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6:128.","journal-title":"Signal Transduct Target Ther"},{"key":"1808_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99\u2013103. https:\/\/doi.org\/10.1038\/nature22393. Epub 22017 May 22391.","journal-title":"Nature"},{"key":"1808_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1158\/2159-8290.CD-19-0672","volume":"10","author":"DA Erkes","year":"2020","unstructured":"Erkes DA, Cai W, Sanchez IM, Purwin TJ, Rogers C, Field CO, et al. Mutant BRAF and MEK inhibitors regulate the tumor immune microenvironment via pyroptosis. Cancer Discov. 2020;10:254\u201369.","journal-title":"Cancer Discov"},{"key":"1808_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","volume":"23","author":"L Galluzzi","year":"2024","unstructured":"Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM. Targeting immunogenic cell stress and death for cancer therapy. Nat Rev Drug Discov. 2024;23:445\u201360.","journal-title":"Nat Rev Drug Discov"},{"key":"1808_CR17","doi-asserted-by":"crossref","unstructured":"Proctor M, Gonzalez Cruz JL, Daignault-Mill SM, Veitch M, Zeng B, Ehmann A, et al. Targeting replication stress using CHK1 inhibitor promotes innate and NKT cell immune responses and tumour regression. Cancers (Basel). 2021;13.","DOI":"10.3390\/cancers13153733"},{"key":"1808_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/pcmr.13120","volume":"37","author":"Z Zeng","year":"2024","unstructured":"Zeng Z, Ngo HL, Proctor M, Rizos H, Dolcetti R, Cruz JG, et al. Checkpoint kinase 1 inhibitor\u2009+\u2009low-dose hydroxyurea efficiently kills BRAF inhibitor- and immune checkpoint inhibitor-resistant melanomas. Pigment Cell Melanoma Res. 2024;37:45\u201350.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1808_CR19","doi-asserted-by":"crossref","unstructured":"Goh NLL, Abdul Rahim NJ, Bhatt R, Ong SE, Lim KY, Gandini A, et al. Checkpoint kinase 1 inhibitor combined with low dose hydroxyurea promotes ATM-activated NF-\u03baB-dependent pro-inflammatory chemokine expression in melanomas. Cancers (Basel). 2025;17:1817.","DOI":"10.3390\/cancers17111817"},{"key":"1808_CR20","doi-asserted-by":"crossref","unstructured":"Lim Y, De Bellis D, Sandow JJ, Capalbo L, D\u2019Avino PP, Murphy JM, et al. Phosphorylation by aurora B kinase regulates caspase-2 activity and function. Cell Death Differ. 2020;28:349\u201366.","DOI":"10.1038\/s41418-020-00604-y"},{"key":"1808_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63168-w","volume":"16","author":"MJK Jones","year":"2025","unstructured":"Jones MJK, Rai SK, Pfuderer PL, Bonfim-Melo A, Pagan JK, Clarke PR, et al. A high-resolution, nanopore-based artificial intelligence assay for DNA replication stress in human cancer cells. Nat Commun. 2025;16:7732.","journal-title":"Nat Commun"},{"key":"1808_CR22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"1808_CR23","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/1878-0261.12497","volume":"13","author":"ZY Oo","year":"2019","unstructured":"Oo ZY, Proctor M, Stevenson AJ, Nazareth D, Fernando M, Daignault SM, et al. Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine. Mol Oncol. 2019;13:1503\u201318. https:\/\/doi.org\/10.1002\/1878-0261.12497.","journal-title":"Mol Oncol"},{"key":"1808_CR24","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1080\/15384101.2018.1547001","volume":"17","author":"GD Grant","year":"2018","unstructured":"Grant GD, Kedziora KM, Limas JC, Cook JG, Purvis JE. Accurate delineation of cell cycle phase transitions in living cells with PIP-FUCCI. Cell Cycle. 2018;17:2496\u2013516.","journal-title":"Cell Cycle"},{"key":"1808_CR25","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1158\/1541-7786.MCR-22-0040","volume":"20","author":"M Vernon","year":"2022","unstructured":"Vernon M, Wilski NA, Kotas D, Cai W, Pomante D, Tiago M, et al. Raptinal induces gasdermin E-dependent pyroptosis in naive and therapy-resistant melanoma. Mol Cancer Res. 2022;20:1811\u201321.","journal-title":"Mol Cancer Res"},{"key":"1808_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14128","volume":"8","author":"C Rogers","year":"2017","unstructured":"Rogers C, Fernandes-Alnemri T, Mayes L, Alnemri D, Cingolani G, Alnemri ES. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death. Nat Commun. 2017;8:14128. https:\/\/doi.org\/10.1038\/ncomms14128.","journal-title":"Nat Commun"},{"key":"1808_CR27","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/s41418-023-01143-y","volume":"30","author":"SS Oltra","year":"2023","unstructured":"Oltra SS, Colomo S, Sin L, P\u00e9rez-L\u00f3pez M, L\u00e1zaro S, Molina-Crespo A, et al. Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells. Cell Death Differ. 2023;30:1366\u201381.","journal-title":"Cell Death Differ"},{"key":"1808_CR28","doi-asserted-by":"publisher","first-page":"13432","DOI":"10.1074\/jbc.272.20.13432","volume":"272","author":"Z Han","year":"1997","unstructured":"Han Z, Hendrickson EA, Bremner TA, Wyche JH. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro *. J Biol Chem. 1997;272:13432\u20136.","journal-title":"J Biol Chem"},{"key":"1808_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09397-2","volume":"10","author":"C Rogers","year":"2019","unstructured":"Rogers C, Erkes DA, Nardone A, Aplin AE, Fernandes-Alnemri T, Alnemri ES. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun. 2019;10:1689.","journal-title":"Nat Commun"},{"key":"1808_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41418-018-0110-y","volume":"26","author":"M Poreba","year":"2019","unstructured":"Poreba M, Groborz K, Navarro M, Snipas SJ, Drag M, Salvesen GS. Caspase selective reagents for diagnosing apoptotic mechanisms. Cell Death Differ. 2019;26:229\u201344.","journal-title":"Cell Death Differ"},{"key":"1808_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell. 2005;17:393\u2013403.","journal-title":"Mol Cell"},{"key":"1808_CR32","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.cell.2008.03.037","volume":"133","author":"S Sidi","year":"2008","unstructured":"Sidi S, Sanda T, Kennedy RD, Hagen AT, Jette CA, Hoffmans R, et al. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell. 2008;133:864\u201377.","journal-title":"Cell"},{"key":"1808_CR33","doi-asserted-by":"crossref","unstructured":"Brown-Suedel AN, Bouchier-Hayes L. Caspase-2 substrates: to apoptosis, cell cycle control, and beyond. Front Cell Dev Biol. 2020;8:610022.","DOI":"10.3389\/fcell.2020.610022"},{"key":"1808_CR34","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/sj.cr.7310112","volume":"16","author":"AB Berger","year":"2006","unstructured":"Berger AB, Sexton KB, Bogyo M. Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity. Cell Res. 2006;16:961\u20133.","journal-title":"Cell Res"},{"key":"1808_CR35","doi-asserted-by":"crossref","unstructured":"Wilski-Cronin NA, Erkes DA, Purwin TJ, Melissaratos DS, Stefanski CD, Caksa S, et al. Pyroptosis modulates multiple immune cell populations in targeted therapy\u2013treated melanoma. Cancer Immunol Res. 2026: OF1-OF13.","DOI":"10.1158\/2326-6066.31484036"},{"key":"1808_CR36","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1038\/s41418-023-01211-3","volume":"30","author":"X Li","year":"2023","unstructured":"Li X, Zhang T, Kang L, Xin R, Sun M, Chen Q, et al. Apoptotic caspase-7 activation inhibits non-canonical pyroptosis by GSDMB cleavage. Cell Death Differ. 2023;30:2120\u201334.","journal-title":"Cell Death Differ"},{"key":"1808_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.907036","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Wang S, Blokhuis B, Ruijtenbeek R, Garssen J, Redegeld F. Cell death triggers induce MLKL cleavage in multiple myeloma cells, which may promote cell death. Front Oncol. 2022;12:907036.","journal-title":"Front Oncol"},{"key":"1808_CR38","doi-asserted-by":"publisher","first-page":"15072","DOI":"10.1073\/pnas.1408987111","volume":"111","author":"JM Hildebrand","year":"2014","unstructured":"Hildebrand JM, Tanzer MC, Lucet IS, Young SN, Spall SK, Sharma P, et al. Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death. Proc Natl Acad Sci. 2014;111:15072\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"1808_CR39","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.4049\/jimmunol.2000373","volume":"204","author":"S Matikainen","year":"2020","unstructured":"Matikainen S, Nyman TA, Cypryk W. Function and Regulation of Noncanonical Caspase-4\/5\/11 Inflammasome. J Immunol. 2020;204:3063\u20139.","journal-title":"J Immunol"},{"key":"1808_CR40","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1124\/jpet.106.111344","volume":"321","author":"W Wannamaker","year":"2007","unstructured":"Wannamaker W, Davies R, Namchuk M, Pollard J, Ford P, Ku G, et al. (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2 R,3 S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1\u03b2 and IL-18. s J Pharm Exp Ther. 2007;321:509\u201316.","journal-title":"s J Pharm Exp Ther"},{"key":"1808_CR41","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.cell.2020.03.040","volume":"181","author":"M Zheng","year":"2020","unstructured":"Zheng M, Karki R, Vogel P, Kanneganti T-D. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense. Cell. 2020;181:674\u2013e613.","journal-title":"Cell"},{"key":"1808_CR42","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.celrep.2017.04.010","volume":"19","author":"S Horn","year":"2017","unstructured":"Horn S, Hughes MA, Schilling R, Sticht C, Tenev T, Ploesser M, et al. Caspase-10 negatively regulates caspase-8-mediated cell death, switching the response to CD95L in favor of NF-\u03baB activation and cell survival. Cell Rep. 2017;19:785\u201397.","journal-title":"Cell Rep"},{"key":"1808_CR43","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1091\/mbc.e05-12-1107","volume":"17","author":"C Bonzon","year":"2006","unstructured":"Bonzon C, Bouchier-Hayes L, Pagliari LJ, Green DR, Newmeyer DD. Caspase-2\u2013induced apoptosis requires bid cleavage: a physiological role for bid in heat shock\u2013induced death. Mol Biol Cell. 2006;17:2150\u20137.","journal-title":"Mol Biol Cell"},{"key":"1808_CR44","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/cdd.2010.135","volume":"18","author":"ZT Schug","year":"2011","unstructured":"Schug ZT, Gonzalvez F, Houtkooper RH, Vaz FM, Gottlieb E. BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane. Cell Death Differ. 2011;18:538\u201348.","journal-title":"Cell Death Differ"},{"key":"1808_CR45","doi-asserted-by":"publisher","first-page":"15749","DOI":"10.1074\/jbc.M209208200","volume":"278","author":"MD Esposti","year":"2003","unstructured":"Esposti MD, Ferry G, Masdehors P, Boutin JA, Hickman JA, Dive C. Post-translational modification of bid has differential effects on its susceptibility to cleavage by caspase 8 or caspase 3*. J Biol Chem. 2003;278:15749\u201357.","journal-title":"J Biol Chem"},{"key":"1808_CR46","doi-asserted-by":"publisher","first-page":"39246","DOI":"10.1074\/jbc.M505009200","volume":"280","author":"H Niida","year":"2005","unstructured":"Niida H, Tsuge S, Katsuno Y, Konishi A, Takeda N, Nakanishi M. Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J Biol Chem. 2005;280:39246\u201352.","journal-title":"J Biol Chem"},{"key":"1808_CR47","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1158\/1078-0432.CCR-17-2701","volume":"24","author":"ZY Oo","year":"2018","unstructured":"Oo ZY, Stevenson AJ, Proctor M, Daignault SM, Walpole S, Lanagan C, et al. Endogenous replication stress marks melanomas sensitive to CHEK1 inhibitors in vivo. Clin Cancer Res. 2018;24:2901\u201312.","journal-title":"Clin Cancer Res"},{"key":"1808_CR48","doi-asserted-by":"crossref","unstructured":"Dawar S, Lim Y, Puccini J, White M, Thomas P, Bouchier-Hayes L, et al. Caspase-2-mediated cell death is required for deleting aneuploid cells. Oncogene. 2016;36:2704\u201314.","DOI":"10.1038\/onc.2016.423"},{"key":"1808_CR49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41577-020-0297-2","volume":"20","author":"K Minton","year":"2020","unstructured":"Minton K. Pyroptosis heats tumour immunity. Nat Rev Immunol. 2020;20:274\u20135.","journal-title":"Nat Rev Immunol"},{"key":"1808_CR50","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","volume":"579","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579:415\u201320.","journal-title":"Nature"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01808-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01808-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01808-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:37:41Z","timestamp":1783687061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01808-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":50,"alternative-id":["1808"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01808-4","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No animal or human subjects or samples were used in this study. All cell lines were established and publicly available. All experiments were conducted according to the institutional Biosafety Committee of The University of Queensland and according to the National Health and Medical Research Council of Australia guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}